# EDGAR Filing Document

**Accession Number:** 0001699382
**File Stem:** 0001140361-26-016039
**Filing Date:** 2026-4
**Character Count:** 2092
**Document Hash:** 5fed22847d3528182c37df9cdf4ce99e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-016039.hdr.sgml**: 20260422

**ACCESSION NUMBER**: 0001140361-26-016039

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260422

**DATE AS OF CHANGE**: 20260422

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PMV Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001699382
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 463218129
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39539
- **FILM NUMBER:** 26881333

**BUSINESS ADDRESS:**
- **STREET 1:** 400 ALEXANDER PARK DRIVE
- **STREET 2:** SUITE 301
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540
- **BUSINESS PHONE:** (609) 642-6670

**MAIL ADDRESS:**
- **STREET 1:** 400 ALEXANDER PARK DRIVE
- **STREET 2:** SUITE 301
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540

### UNITED STATES<br>

### SECURITIES AND EXCHANGE COMMISSION<br>

### Washington, D.C. 20549

### SCHEDULE 14A

#### PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE<br>

#### SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐<br> Preliminary Proxy Statement

 **☐** **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☐<br> Definitive Proxy Statement

☒<br> Definitive Additional Materials

☐<br> Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-2

---

| |
|:---|
| **PMV PHARMACEUTICALS, INC.**  |
| **(Name of Registrant as Specified In Its Charter)** |
| **(Name of Person(s) Filing Proxy Statement, if other than the Registrant)** |

---

Payment of Filing Fee (Check the appropriate box):

☒ No fee required. <br> ☐ Fee paid previously with preliminary materials. <br> ☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

------

![](ny20064070x2_nc01.jpg)<br>

------

![](ny20064070x2_nc02.jpg)<br>

------